Adverum Biotechnologies Inc’s filing revealed that its CHIEF OPERATING OFFICER Soparkar Peter unloaded Company’s shares for reported $5920.0 on May 15 ’25. In the deal valued at $2.00 per share,2,960 shares were sold. As a result of this transaction, Soparkar Peter now holds 39,154 shares worth roughly $0.1 million.
Then, Seyedkazemi Setareh sold 924 shares, generating $1,848 in total proceeds. Upon selling the shares at $2.00, the CHIEF DEVELOPMENT OFFICER now owns 13,768 shares.
Before that, Fischer Laurent sold 9,126 shares. Adverum Biotechnologies Inc shares valued at $18,252 were divested by the CEO, PRESIDENT AND DIRECTOR at a price of $2.00 per share. As a result of the transaction, Fischer Laurent now holds 87,488 shares, worth roughly $0.23 million.
Oppenheimer initiated its Adverum Biotechnologies Inc [ADVM] rating to an Outperform in a research note published on June 25, 2024; the price target was $25. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late April with a ‘”a Buy”‘ rating. Truist also remained covering ADVM and has increased its forecast on July 07, 2022 with a “Buy” recommendation from previously “Hold” rating. Cantor Fitzgerald revised its rating on July 23, 2021. It rated ADVM as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of ADVM
On Tuesday, Adverum Biotechnologies Inc [NASDAQ:ADVM] saw its stock fall -1.48% to $2.67. Over the last five days, the stock has gained 1.52%. Adverum Biotechnologies Inc shares have fallen nearly -71.84% since the year began. Nevertheless, the stocks have fallen -42.83% over the past one year. While a 52-week high of $8.58 was reached on 03/21/25, a 52-week low of $1.78 was recorded on 05/15/25.
Levels Of Support And Resistance For ADVM Stock
The 24-hour chart illustrates a support level at 2.61, which if violated will result in even more drops to 2.54. On the upside, there is a resistance level at 2.77. A further resistance level may holdings at 2.87.
How much short interest is there in Adverum Biotechnologies Inc?
A steep rise in short interest was recorded in Adverum Biotechnologies Inc stocks on 2025-06-30, dropping by -0.78 million shares to a total of 1.16 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 1.94 million shares. There was a decline of -67.39%, which implies that there is a negative sentiment for the stock.
